Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 748 shares at $18.61 ($14K) on 2026-07-28, disclosed to the SEC on 2026-07-30.
Seasonal sale ($14k) by See remarks — this insider has traded RLAY in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |
| RLAY | SELL | 2025-10-30 | $439K | — | Filing → |